ArticleWorld journal of surgical oncology2025
Successful treatment of osimertinib-resistant EGFR-mutant NSCLC with acquired BRAF V600E mutation using triple combination therapy: a case report with pathological confirmation.
MingHui Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.